Cover Image

Bladder Cancer Diagnosis, Therapeutics, and Management /

In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cance...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Lee, Cheryl T. (Editor), Wood, David P. (Editor)
Format: Electronic
Language:English
Published: Totowa, NJ : Humana Press, 2010.
Series:Current Clinical Urology
Subjects:
Medicine.
Urology.
Medicine & Public Health.
Urology/Andrology.
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-59745-417-9
Table of Contents:
  • Part I. Improving Bladder Cancer Staging
  • Section 1. CIS
  • Approach to CIS.-Fluorescent Cystoscopy
  • Section 2. Understaging
  • Restaging TURBT
  • Understaging T2: Limitations of Pelvic Imaging
  • MRI Endorectal Coil
  • PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease
  • Detection of Extravesical Disease: A Lack of Bladder Cancer Markers
  • Identification of Nodal Metastases: The Role of Iron Oxide Enhanced MRI
  • Presence and Significance of Micrometastases
  • Part II. Optimizing Treatment of Localized Disease
  • Section 1: Intravesical Therapy
  • Peri-operative intravesical therapy
  • BCG Refractory Disease
  • Beyond BCG: Gemcitabine
  • Beyond BCG: Taxanes
  • Section 2: Cystectomy: Cancer Control and Organ Preservation
  • Extended Lymph Node Dissection
  • Prostate Capsule Sparing Cystectomy
  • Preservation of Reproductive Organs in Women
  • Nerve Sparing Cystectomy
  • Quality of Care Indicators for Radical Cystectomy
  • Continent Diversion: Problems and Solutions
  • Continent Diversion: QOL of Orthotopic Diversion vs Ileal Conduit
  • Voiding Dysfunction After Orthotopic Diversion
  • Overcoming the Stigma of Complications of Continent Cutaneous Diversion
  • Part III. Locally Advanced / Distant Disease: Multi-Modality treatment
  • Neoadjuvant Chemotherapy: The New Standard
  • Adjuvant Therapy: A Good Concept But Wheres the Proof
  • Beyond MVAC: New and Improved Chemotherapeutics
  • Part IV: Next Steps: Translational Research
  • The Role of Microarray Technologies in Bladder Cancer Management
  • Development of Novel Agents / Targeted Therapies
  • Tools for Study: National Databanking
  • Vaccine Development
  • Advances in Gene Therapy for Bladder Cancer.

Similar Items